43.69
Doximity Inc 주식(DOCS)의 최신 뉴스
How Doximity Inc stock reacts to global recession fears2025 Earnings Surprises & Reliable Intraday Trade Plans - moha.gov.vn
Rice Hall James & Associates LLC Sells 35,852 Shares of Doximity, Inc. $DOCS - MarketBeat
HALPER SADEH LLC ENCOURAGES DOXIMITY INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Doximity (NASDAQ:DOCS) Sets New 1-Year LowHere's Why - MarketBeat
Doximity (DOCS) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Doximity stock hits 52-week low at 43.28 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.28 USD - Investing.com
Doximity (DOCS) Stock Trades Up, Here Is Why - Finviz
Why Doximity (DOCS) is a Top Growth Stock for the Long-Term - Nasdaq
Riverbridge Partners LLC Has $40.61 Million Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Why BofA Sees Strong Upside for Doximity (DOCS) - Finviz
BTIG Upgrades Doximity (DOCS) Stock to Buy from Neutral - MSN
Is Doximity Inc. stock attractive for long term wealth buildingJuly 2025 Reactions & Community Driven Trade Alerts - bolumsonucanavari.com
Is Doximity Inc. Class stock considered safe havenJuly 2025 Institutional & Target Return Focused Stock Picks - Улправда
Doximity, Inc. $DOCS Shares Purchased by Voya Investment Management LLC - MarketBeat
Clinical decision support's new chessboard - Axios
Will Doximity Inc. stock outperform tech sector in 2025Forecast Cut & Short-Term High Return Ideas - Улправда
How Doximity Inc. stock compares to industry benchmarksWeekly Market Report & Technical Confirmation Alerts - DonanımHaber
How higher bond yields impact Doximity Inc. Class stockDollar Strength & High Accuracy Trade Alerts - DonanımHaber
How Doximity Inc. stock reacts to global recession fearsWeekly Profit Analysis & Target Return Focused Picks - DonanımHaber
How rising interest rates impact Doximity Inc. stockBond Market & Weekly Breakout Opportunity Watchlist - Улправда
Doximity (NASDAQ:DOCS) Hits New 12-Month LowShould You Sell? - MarketBeat
How Analyst Upgrades Highlighting AI Tools And Ad Shift Potential At Doximity (DOCS) Has Changed Its Investment Story - Yahoo Finance
Is Analyst Upgrades on AI Workflow and Pharma Ads Altering The Investment Case For Doximity (DOCS)? - Sahm
Doximity (DOCS): Assessing Valuation After Analyst Upgrades and Growing AI-Driven Growth Prospects - Sahm
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying By Investing.com - Investing.com South Africa
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends By Investing.com - Investing.com South Africa
Doximity stock hits 52-week low at 43.59 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.59 USD - Investing.com India
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying - Investing.com India
BofA Securities maintains Buy rating on Doximity stock amid pharma ad trends - Investing.com Nigeria
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event - Investing.com Nigeria
Texas Permanent School Fund Corp Acquires 82,274 Shares of Doximity, Inc. $DOCS - MarketBeat
How Doximity is looking to break through AI skepticism - Modern Healthcare News
Doximity (DOCS) ascends while market falls: Some facts to note - MSN
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note - sharewise.com
Doximity (DOCS): Taking Stock of Valuation After Analyst Upgrades on AI Tools and Growth Outlook - Yahoo Finance
Doximity Sees Surge as AI Tools and Analyst Ratings Impress - StocksToTrade
Is Doximity Now an Opportunity After Recent Share Price Slide? - Yahoo Finance
Doximity rises after Morgan Stanley upgrades to 'overweight' - TradingView — Track All Markets
Doximity upgraded at Morgan Stanley on expanding market for HCP platforms - MSN
Doximity (NASDAQ:DOCS) Shares Gap UpStill a Buy? - MarketBeat
Doximity Offers Attractive Entry Point, Morgan Stanley Says - marketscreener.com
Doximity’s underperformance at odds with improving business, says MS - Investing.com
Morgan Stanley Upgrades Doximity to Overweight From Equalweight, Raises Price Target to $65 From $62 - marketscreener.com
Morgan Stanley upgrades Doximity stock to Overweight on conservative outlook - Investing.com Canada
Doximity (DOCS) Stock Trends and Sentiment 2025 - MarketBeat
Doximity, Inc. (NYSE:DOCS) Q2 2026 Earnings Call Transcript - MSN
자본화:
|
볼륨(24시간):